BioSpace News Archive

Deployment of Microtox® PD and Microtox® BT Novel Sensors for identification of pathogenic viruses including SARS-CoV-2

Isofol Medical AB, provided an update on the extension study portion of the ISO-CC-005 Phase I/IIa study.

During September, Calliditas Therapeutics AB has allotted 111,250 common shares within the company’s warrant program issued in 2017.

TaiGen Biotechnology Company, Limited announced that they have signed an exclusive licensing agreement with Luminarie Canada Inc., a leading Canadian pharmaceutical company, to develop and commercialize Taigexyn® in Canada, Australia and New Zealand.

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapies for neurodegenerative diseases, announced the presentation of a poster titled, “Advancing NurOwn® for ALS: Phase 3 Clinical Trial Design” at the Annual Northeast ALS Meeting, being held virtually.

C-RAD announced that multiple sites in the state of New South Wales, Australia decided to implement C-RAD’s Catalyst+ HD™ and Sentinel 4DCT™ solution.

SentiAR, a pioneer in visualization technologies for surgical applications announces U.S. Food and Drug Administration 510 clearance of its groundbreaking CommandEP™ system, the first holographic guidance system to be used during an invasive cardiac procedure.

BioCryst Pharmaceuticals, Inc. announced new data from treatment-naïve paroxysmal nocturnal hemoglobinuria patients receiving doses through 400 mg bid of its oral Factor D inhibitor, BCX9930, as monotherapy in an ongoing dose-ranging trial.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a New Drug Application to the U.S. FDA for UPTRAVI® as an injection for intravenous use for the treatment of pulmonary arterial hypertension in adults with WHO functional class II–III, who are currently prescribed oral UPTRAVI but are temporarily unable to take oral therapy.

Value Partnership builds on the long-standing relationship between Siemens Healthineers and WakeMed Health & Hospitals